Abstract submission guidelines for moderated poster and podium sessions
Please follow these instructions carefully. Abstracts not prepared correctly will not be considered for presentation. Corrected abstracts cannot be accepted. Authors will be informed on the acceptance of their abstracts by March 6, 2017.
Submitted abstracts will be graded individually by peer reviewers based on scientific merit and originality. Abstracts must be written in English and, if accepted, presented in English. The WAS Scientific Committee will determine the format of the presentation. The total number of abstracts allowed to be presented by the same author is 3. Accepted abstracts will be assigned for presentation at a podium session or a moderated poster session at the discretion of the WAS scientific Committee. High quality abstracts in select categories may be chosen for presentation on the Symposia Sessions. Abstracts not selected for the Podium or Moderated Poster Session will be considered for presentation as a Poster at the congress. Please check the box if you do NOT wish your abstract to be considered for this option.
Preparation of Abstracts
The size of the abstract is limited to 300 words. The abstract title, names of authors and affiliations are not included in the word count. Please do not submit any tables or figures in the abstract.
The title should clearly define the topic and contain no abbreviations.
List the primary author’s full name, followed by the other authors’ names. Spell out completely the names of all authors using full first name, middle / initial and last name. (Maintain consistency in authors’ names on multiple abstracts to avoid duplication in the Author Index) Authors’ affiliations should be indicated by numbered superscripts with the name of the respective institution(s), city and country typed in upper and lower case and single-spaced without using full-stops.
If the author(s) of the abstract is an employee(s) of or has a financial relationship with the commercial interest which controls the content of the presentation, then he/she cannot be the presenting author. However, principal investigators responsible for research and development are permitted to present as long as they resolve their COI and as long as they are not employees of the commercial interest. In all printed publications the presenting author will be denoted with an asterisk (*). Please note: As of March 31, 2017 no changes to the Presenting Author will be made in the Program / Abstract Publication.
Body of Abstract
The authors are fully responsible for the quality and styling of the abstract contents. Please type the text in single-spaces with no indentations, taking a new line for each new paragraph (introduction, methods, results and conclusion). Do not include non-standard symbols, as they will not be recognized and may be displayed wrongly.
- The body must contain 4 separate paragraphs: a) Introduction and Objective, b) Methods, c) Results and d) Conclusions.
- It is NOT acceptable to state that “The results will be discussed.” Inclusion of specific data is helpful to the reviewers.
- Indicate the major new findings of the study.
- Standard abbreviations may be used as follows: on first use spell out the full term and follow with the abbreviation in parentheses.
- Proprietary names of drugs are not allowed; generic names must be used.
Source of Funding
Grant support must be indicated in the form. If there is no support, “None” must be listed. This is a required field in the submission process.
Abstracts deemed to be purely for marketing purposes will not be accepted.
Conflict of Interest and Disclosure Statement
All authors must disclose conflicts of interest. The submission process will not allow abstracts to be submitted without this information being completed for each author listed on the abstract.
Authors must select a suitable track and area (only one) from the provided list below. For example: if the work pertains to ‘Bio-medical Research’ in the area of ‘Depression/Anxiety and Sexuality’, the abstract category will be: 3.7.
Abstract category listing
- Basic Research (basic processes, neuro-physiological processes)
- Behavioural, Social & Historical Research (non-clinical)
- Bio-medical Research (basic, pharmacological, clinical)
- Clinical Research & Practice (psychotherapy, sex therapy, couple therapy)
- Public Health, Epidemiology & Public Policies
- Sexual Health & Sexual Rights (actions and advocacy)
- Sexuality Education
- Adolescents Sexuality
- Aging and Sexuality
- Clinical Sexology
- Commercial Sex Work
- Couple Therapy
- Culture and Sexuality
- Depression/Anxiety and Sexuality
- Disability and Sexuality
- Drugs and Sexuality
- DSM-5 and ICD-11
- Evolutionary Sexology
- Female and Male Sexuality
- Gender and Sexuality
- Genital Cutting and Modifications
- History and Sexuality
- HIV, AIDS, STI and Sexuality
- Hormones, Contraception and Sexuality
- Law and Sexuality
- Medical Conditions and Sexuality
- Minorities and Marginalized Groups
- National Surveys of Sexual Behaviour
- Neuroimaging of Sexual Response
- Neurological Disorders and Sexuality
- Out of Control Sexual Behaviour
- Politics and Sexuality
- Pregnancy and Sexuality
- Religion and Sexuality
- Romantic Love
- Sex and the Internet
- Sexual and Reproductive Health
- Sexual Dysfunctions
- Sexual Education
- Sexual Medicine
- Sexual Preferences
- Sexual Rights
- Sexual Satisfaction and Well-being
- Sexuality and Life-span Development
- Transgender & Transsexualism
- Violence and Sex (violence, child abuse, rape)
Authors must provide up to 3 keywords that best describes the subject of the abstract.
Please do not submit the same abstract more than once. If changes to your already submitted abstract are necessary or in case of difficulties during submission, please contact us by email (email@example.com) at any time before the deadline.
Note to all presenters
The Organizing Committee reserves the right to amend or change any part of the submission guidelines without prior notice.